PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2075349
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2075349
Thromboelastography Market, By Type, By Application, By End User, and By Region Size, Share, Outlook, and Opportunity Analysis, 2025 - 2032
Thromboelastography Market is estimated to be valued at USD 796.2 Mn in 2026 and is expected to reach USD 1,303.8 Mn by 2033, growing at a compound annual growth rate (CAGR) of 7.3% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 796.2 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 7.30% | 2033 Value Projection: | USD 1,303.8 Mn |
The thromboelastography protects against the severe blood loss or hemorrhage occurred during severe injury or during a surgery. Thromboelastography (TEG) is more frequently used in cardiac surgery, organ transplants, and arteriovenous malformation surgeries where the anticipated blood loss is greater than 40% of the circulating blood volume because it performs an in vitro analysis of the relationship between platelets, enzymes, fibrinogen, and other coagulation elements in a comprehensive manner. Through platelet mapping, patients using antiaggregants like clopidogrel or aspirin can have their platelet activity assessed. This is made possible by include TEG in the pre-anesthetic assessment.
Market Dynamics
Increasing initiatives in developing new methods by market players is expected to boost the growth of global thromboelastography market over the forecast period. For instance, on February 20, 2022, an article published in national library of medicine, asserted that Coagulopathies pose additional diagnostic and therapeutic difficulties in the field of otolaryngology-head and neck surgery (ENT). Management of coagulopathies in both hyper- and hypocoagulable individuals necessitates careful consideration of the nature of hemostatic competence. Viscoelastic tests (VETs) such as thromboelastography (TEG) and rotational thromboelastometry (ROTEM) have long been methods of guiding blood component therapy (BCT). VETs have been widely adopted for the diagnosis and management of trauma-induced coagulopathy and bleeding conditions.
Increasing in the rate of new approvals by regulatory authorities such as the U.S. FDA is likely to boost the growth of global thromboelastography market over the forecast period. For instance, on January 11, 2021, Abbott Laboratories is a multinational company engaged in manufacturing and research of medical devices and health care products. Abbott received an FDA 510(k) clearance for the first rapid handheld blood test for concussion. The i-STAT Alinity handheld device from Abbott will be used to provide the test to help diagnose mild traumatic brain injury (TBI), also known as concussion. The test results are available 15 minutes after inserting a plasma sample.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global thromboelastography market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, strategies
- Key companies covered as a part of this study include Lepu Medical Technology (Beijing) Co.,Ltd., Render Biotech Co., Haemonetics Corporation, TA Instruments, HemaCore LLC, 5-Diagnostics, Xenometrix AG, Framar Hemologix srl, Instrumentation Laboratory, Medirox AB, Diagnostica Stago, Life Diagnostica, SYCOmed e.K., Nordic Biomarker, and Shenzhen Ultra-Diagnostics Biotec. Co., Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global thromboelastography market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the global thromboelastography market
Detailed Segmentation:
- Global Thromboelastography Market, by Type (Revenue, USD Mn, 2021 - 2033)
- Standard (kaolin)
- Rapid TEG
- Native TEG
- Heparinase
- Functional Fibrinogen
- Platelet Mapping
- Global Thromboelastography Market, by Application (Revenue, USD Mn, 2021 - 2033)
- Cardiopulmonary Bypass
- Liver Surgery
- Trauma surgery
- Obstetrics
- Global Thromboelastography Market, by End User (Revenue, USD Mn, 2021 - 2033)
- Hospitals
- Blood Banks
- Academic Institutes
- Others (Research Laboratories, Research Institutes)
- Global Thromboelastography Market, By Region (Revenue, USD Mn, 2021 - 2033)
- North America
- By Country:
- U.S.
- Canada
- By Country:
- Latin America
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- By Country:
- Europe
- By Country:
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- By Country:
- Asia Pacific
- By Country:
- Australia
- India
- China
- Japan
- ASEAN
- South Korea
- Rest of Asia Pacific
- By Country:
- Middle East
- By Country:
- GCC
- Israel
- Rest of Middle East
- By Country:
- Africa
- By Country/Region:
- South Africa
- Central Africa
- North Africa
- By Country/Region:
- Company Profiles
- Lepu Medical Technology (Beijing) Co.,Ltd *
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Render Biotech Co.
- Haemonetics Corporation
- TA Instruments
- HemaCore LLC
- 5-Diagnostics
- Xenometrix AG
- Framar Hemologix srl
- Instrumentation Laboratory
- Medirox AB
- Diagnostica Stago
- Life Diagnostica
- SYCOmed e.K.
- Nordic Biomarker
- Shenzhen Ultra-Diagnostics Biotec. Co., Ltd.
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunity
- Impact Analysis
- Key Developments
- Industry Trends
- Regulatory Scenario
- Recent Product Approval/Launches
- PEST Analysis
- Porter's Analysis
4. Global Thromboelastography Market, By Type, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Standard (kaolin)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Rapid TEG
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Native TEG
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Heparinase
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Functional Fibrinogen
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Platelet Mapping
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
5. Global Thromboelastography Market, By Application, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Cardiopulmonary Bypass
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Liver Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Trauma surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Obstetrics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
6. Global Thromboelastography Market, By End User, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Blood Banks
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Academic Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Others (Research Laboratories, Research Institutes)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
7. Global Thromboelastography Market, By Region, 2021 - 2033 (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033(%)
- Y-o-Y Growth Analysis, For Regions, 2022 - 2033
- Regional Trends
- North America
- Market Size and Forecast, By Type, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Application, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By End User, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Country, 2021 - 2033 (US$ Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Type, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Application, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By End User, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Country, 2021 - 2033 (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Type, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Application, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By End User, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Country, 2021 - 2033 (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Type, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Application, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By End User, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Country, 2021 - 2033 (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Market Size and Forecast, By Type, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Application, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By End User, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Country, 2021 - 2033 (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Type, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Application, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By End User, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Region/Country, 2021 - 2033 (US$ Mn)
- South Africa
- Central Africa
- North Africa
8. Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Lepu Medical Technology (Beijing) Co.,Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Render Biotech Co.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Haemonetics Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- TA Instruments
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- HemaCore LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- 5-Diagnostics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Xenometrix AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Framar Hemologix srl
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Instrumentation Laboratory
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Medirox AB
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Diagnostica Stago
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Life Diagnostica
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- SYCOmed e.K.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Nordic Biomarker
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Shenzhen Ultra-Diagnostics Biotec. Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Lepu Medical Technology (Beijing) Co.,Ltd.
- Analyst Views
9. Section
- Research Methodology
- About Us
